PT Jayamas Medica Industri Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024 - Marketscreener.com
| OMED Stock | 176.00 6.00 3.30% |
About 62% of Jayamas Medica's investor base is looking to short. The analysis of current outlook of investing in Jayamas Medica Industri suggests that many traders are alarmed regarding Jayamas Medica's prospects. Jayamas Medica's investing sentiment shows overall attitude of investors towards Jayamas Medica Industri.
Jayamas |
PT Jayamas Medica Industri Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024 Marketscreener.com
Read at news.google.com
 |
Jayamas Medica Fundamental Analysis
We analyze Jayamas Medica's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jayamas Medica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jayamas Medica based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
Jayamas Medica is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Jayamas Medica Industri Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Jayamas Medica stock to make a market-neutral strategy. Peer analysis of Jayamas Medica could also be used in its relative valuation, which is a method of valuing Jayamas Medica by comparing valuation metrics with similar companies.
Peers
Jayamas Medica Related Equities
| KBLV | First Media | 1.19 | ||||
| TECH | Indosterling Technomedia | 0.00 | ||||
| EPMT | Enseval Putra | 0.43 | ||||
| DMND | Diamond Food | 1.25 | ||||
| MNCN | Media Nusantara | 1.40 | ||||
| WINE | PT Hatten | 1.46 |
Other Information on Investing in Jayamas Stock
Jayamas Medica financial ratios help investors to determine whether Jayamas Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jayamas with respect to the benefits of owning Jayamas Medica security.